Plasma levels of procaine amide after administration of conventional and sustained-release tablets.
D000107:Acetylation; D000284:Administration, Oral; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D002849:Chromatography, Gas; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D007700:Kinetics; D008012:Lidocaine / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy; D011342:Procainamide / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood* / Q000627:therapeutic use / Q000652:urine; D013607:Tablets; D013997:Time Factors
D003692:Delayed-Action Preparations; D013607:Tablets; D008012:Lidocaine; D011342:Procainamide